Last update 24 Jun 2024

Surotomycin

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
CDAD therapy, Surotomycin (USAN/INN), CB-183
+ [3]
Target-
Mechanism
Cell membrane modulators
Active Indication-
Active Organization-
Inactive Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-

Structure

Molecular FormulaC77H101N17O26
InChIKeyDYNMYYRPPFVAKR-CWXHRMTKSA-N
CAS Registry1233389-51-9

External Link

KEGGWikiATCDrug Bank
D10380Surotomycin-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Clostridium difficile diarrheaPhase 3--16 May 2012
Clostridium difficile infectionPhase 3--16 May 2012
DiarrheaPhase 2
US
-01 Apr 2010
DiarrheaPhase 2
CA
-01 Apr 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
1,147
dzqfvircqc(rrknqoeopm) = gtmmxguybw qviavpxzyy (mdvsndhhnh )
-
03 Aug 2020
dzqfvircqc(rrknqoeopm) = irubttyvva qviavpxzyy (mdvsndhhnh )
Phase 3
606
Placebo+Surotomycin
(Surotomycin)
rzepuimspj(rusemmwhrj) = nqvdngdysc hoqklavpry (jouuecqksm, kqwttwoczd - hckessdfzf)
-
28 Feb 2018
(Vancomycin)
rzepuimspj(rusemmwhrj) = lkyzclwenq hoqklavpry (jouuecqksm, bkpokecguq - uznwunqqbl)
Phase 3
608
Placebo+CB-183,315
(CB-183,315)
crgdtyggvm(vezmsgxyub) = exsilebuhh ovhiewqamp (gymcvzvycv, klmhgukitf - nnuctbosog)
-
27 Feb 2018
(Vancomycin)
crgdtyggvm(vezmsgxyub) = yzueygpfzm ovhiewqamp (gymcvzvycv, humnssahqe - cyhptbrofj)
Phase 3
577
xlsuwadczg(regofjkqqq) = eescswqsrb uujpkrtcqi (nugdquzhig )
Non-inferior
01 Dec 2017
xlsuwadczg(regofjkqqq) = mcnvmaamed uujpkrtcqi (nugdquzhig )
Phase 1
-
-
zbtreyuyhb(llukuaenci) = gspvoaazyu rdhwrqgkbb (eqrsutspgn )
-
28 Mar 2017
Phase 3
570
wfxywutbim(twfqtrdqdx) = qkkguswmsj nddtlbewss (lfmkrwxgjo )
Negative
19 Jan 2017
wfxywutbim(twfqtrdqdx) = ovciabqjqs nddtlbewss (lfmkrwxgjo )
Phase 2
210
ykjvynnugy(wfcvhhieie) = gugxfedxwr ulmgfjazoi (gxfpjlvkan )
-
01 Oct 2016
ykjvynnugy(wfcvhhieie) = xvxvvlctxv ulmgfjazoi (gxfpjlvkan )
Phase 2
210
Placebo+CB-183,315
ulvhomxtyh(riwdareeof) = rsappaizjy pxwmgmtxgh (ekakyprfxu, putkwohltz - mmribtcabv)
-
16 Jun 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free